[Acute myelitis after immunization against hepatitis B with recombinant vaccine].
Senejoux
A
A
Roulot
D
D
Belin
C
C
Tsakiris
L
L
Rautureau
J
J
Coste
T
T
D000208:Acute Disease; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009187:Myelitis / Q000139:chemically induced* / Q000188:drug therapy; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D005938:Glucocorticoids; D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic; D001623:Betamethasone
Myélite alguë après immunisation contre l'hépatite B par un vaccin recombinant.